| Trial Name: |
Alzheimer's Disease #2
|
| Intro: |
This research study is designed to determine whether imaging of the brain through MRI and PET scans (neuroimaging) every six months can help predict and monitor the onset and progression of Alzheimer's disease |
| Condition: |
|
| Description: |
This research study is designed to determine whether imaging of the brain through MRI and PET scans (neuroimaging) every six months can help predict and monitor the onset and progression of Alzheimer's disease. In addition to neuroimaging, the study will collect and test blood and, for some participants, cerebral spinal fluid, to determine if biomarkers can predict and monitor the disease. |
| Criteria: |
Participants must be between 55 and 90 years of age, be in good general health, be fluent in English, and have either memory problems or a diagnosis of early Alzheimer's disease. Participants must be willing to undergo the test procedures and have a study partner. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back